Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Perioperative haemostasis with full-length, PEGylated, recombinant factor VIII with extended half-life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single-arm phase III trial.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: September 07, 2018
Atypical Hemolytic Uremic Syndrome.
Journal: Pediatric clinics of North America
Published: May 28, 2018
Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia.
Journal: Journal of thrombosis and haemostasis : JTH
Published: February 27, 2018
Subcutaneous diphtheria and tetanus vaccines in children with haemophilia: A pilot study and review of the literature.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 26, 2017
Radionuclide synovectomy/synoviorthesis (RS) in persons with bleeding disorders: A review of impact of national guidance on frequency of RS using the ATHNdataset.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: April 19, 2017
Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab.
Journal: British journal of haematology
Published: November 22, 2016
Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: March 25, 2016
Outcomes in children with deep vein thrombosis managed with percutaneous endovascular thrombolysis.
Journal: Pediatric radiology
Published: May 22, 2014
Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates.
Journal: Transfusion
Published: May 11, 2013
Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE).
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: April 05, 2013
Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening.
Journal: Transfusion
Published: September 25, 2012
Last Updated: 09/26/2026